Recommendations for research

Guidance

The guideline committee has made the following recommendations for research.

What is the clinical utility of bone turnover markers in the diagnosis and management of primary hyperparathyroidism?

For a short explanation of why the committee made the recommendation for research, see the rationale on assessment after diagnosis.

Full details of the evidence and the committee's discussion are in evidence review B: diagnostic tests.

What is the best and most cost-effective management strategy for people whose first surgery for primary hyperparathyroidism is not successful?

For a short explanation of why the committee made the recommendation for research, see the rationale on unsuccessful surgery.

Full details of the evidence and the committee's discussion are in evidence review F: management options in failed primary surgery.

What are the long-term outcomes of different management strategies for primary hyperparathyroidism? Which strategies are most cost effective?

For a short explanation of why the committee made the recommendation for research, see the rationale on all people with primary hyperparathyroidism.

Full details of the evidence and the committee's discussion are in evidence review I: monitoring.

What are the optimal management strategies for primary hyperparathyroidism during pregnancy?

For a short explanation of why the committee made the recommendation for research, see the rationale on care during pregnancy.

Full details of the evidence and the committee's discussion are in evidence review J: pregnancy.